Illig, Carl R.,Chen, Jinsheng,Meegalla, Sanath K.,Wall, Mark J.
申请号：
AU2013203813
公开号：
AU2013203813B2
申请日:
2013.04.11
申请国别(地区):
AU
年份:
2014
代理人:
摘要：
#$%^&*AU2013203813B220140731.pdf#####ABSTRACT The invention is directed to compounds of Formula I wherein Z, X, J, R2 and W are set forth in the specification, as well as solvates, hydrates, tautomers and pharmaceutically 5 acceptable salts thereot that inhibit protein tyrosine kinases, especially e-fins kinase.
